enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Management of Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Parkinson's...

   In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...

3. Gene therapy in Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Gene_therapy_in_Parkinson's...

   Parkinson's disease (PD) is a progressive neurological disorder resulting from the death of cells in the substantia nigra that contain and produce dopamine. People with PD may develop disturbance in their motor activities. Some activities can be tremor or shaking, rigidity and slow movements (bradykinesia).

4. Aromatic L-amino acid decarboxylase inhibitor - Wikipedia

   en.wikipedia.org/wiki/Aromatic_L-amino_acid_de...

   It is used to inhibit the decarboxylation of L-DOPA to dopamine outside the brain, i.e. in the blood. This is primarily co-administered with L -DOPA to combat Parkinson's disease . Administration can prevent common side-effects, such as nausea and vomiting, as a result of interaction with D 2 receptors in the vomiting center (or cheomoreceptor ...

5. Convection enhanced delivery - Wikipedia

   en.wikipedia.org/wiki/Convection_enhanced_delivery

   Animal model research using CED to deliver therapeutics to the brain to treat Parkinson's disease have shown 3 promising therapeutics for treatment. Researchers for these therapeutics have typically used adenovirus carriers for therapeutics since many drugs used to treat Parkinson's disease currently are not chemical based but rather gene ...

6. Catechol-O-methyltransferase inhibitor - Wikipedia

   en.wikipedia.org/wiki/Catechol-O-methyltransfer...

   This enzyme methylates catecholamines such as dopamine, norepinephrine and epinephrine. It also methylates levodopa. COMT inhibitors are indicated for the treatment of Parkinson's disease in combination with levodopa and an aromatic L-amino acid decarboxylase inhibitor (e.g. carbidopa or benserazide).

7. FDA Approves AbbVie's Parkinson's Treatment, Medicare ... - AOL

   www.aol.com/fda-approves-abbvies-parkinsons...

   On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations ...